Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL117724 | 1.00 | CYP1A2 (0.48) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL4829807 | 1.00 | CYP1A2 (0.48) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL29568381 | 1.00 | CYP1A2 (0.48) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Bispyribac SCHEMBL5267344 | 0.99 | CYP1A2 (0.47) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Pyriminobac-Methyl SCHEMBL65714 | 0.90 | ALDH1A1 (0.55) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Pyriminobac-Methyl SCHEMBL29395183 | 0.90 | ALDH1A1 (0.55) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Pyriminobac-Methyl SCHEMBL65713 | 0.90 | ALDH1A1 (0.55) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Pyriminobac-Methyl SCHEMBL32679458 | 0.90 | ALDH1A1 (0.55) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| Pyriminobac-Methyl SCHEMBL4451500 | 0.90 | ALDH1A1 (0.55) | CYP1A2CYP3A4CYP2C9CYP2C19GAA | |
| SCHEMBL17022772 | 0.86 | CYP1A2 (0.42) | CYP1A2CYP3A4CYP2C9CYP2C19GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024031002-A1 | (2,4-DICHLOROPHENOXY)ACETIC ACID ANALOGS | CORTEVA AGRISCIENCE LLC (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20230022569-A1 | COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES WITH ACETOLACTATE SYNTHASE (ALS) INHIBITOR HERBICIDES | CORTEVA AGRISCIENCE LLC (US) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022569-A1 | COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES WITH ACETOLACTATE SYNTHASE (ALS) INHIBITOR HERBICIDES | SOD1, ABAT, ME1 | CYP1A2 574/4885CYP3A4 1156/4885CYP2C9 804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.